title: [New developments in photodynamic therapy].
abstract: We review new developments in recent years in photodynamic therapy. Since 2009 two new photosensitizers, a self-adhesive 5-aminolevulinic acid (ALA) patch and a nanoemulsion formulation of 5-aminolevulinic acid have been approved for the treatment of actinic keratoses. Pretreatment with ablative fractional lasers enhances penetration of the photosensitizer and enables intensified PDT in acral lesions and in field-cancerized skin. Several clinical trials have demonstrated the skin-rejuvenating effects of photodynamic therapy, while the underlying mechanisms of action have been clarified. The efficacy of photodynamic therapy has been shown in the treatment and prophylaxis of actinic keratoses in organ transplant recipients at high risk for developing skin cancer. We also summarize the results of available studies on daylight-mediated photodynamic therapy.
authors.affiliation: Klinik und Poliklinik für Dermatologie, Universitätsklinikum Regensburg, Franz-Josef-Strauss-Allee 11, 93042 Regensburg, Germany.
authors.forename: E
authors.initials: E
authors.lastname: Kohl
authors.forename: S
authors.initials: S
authors.lastname: Karrer
mesh_terms: D021542:Amino Acids, Neutral / Q000008:administration & dosage*; D019317:Evidence-Based Medicine; D006801:Humans; D009381:Neoplasms, Radiation-Induced / Q000209:etiology* / Q000517:prevention & control*; D010778:Photochemotherapy / Q000009:adverse effects* / Q000639:trends*; D017319:Photosensitizing Agents / Q000008:administration & dosage; D012871:Skin Diseases / Q000150:complications / Q000188:drug therapy*
chemical_list: D021542:Amino Acids, Neutral; D017319:Photosensitizing Agents; C013809:5-aminovaleric acid